68Ga-FAPI-46 PET/CT 较 18F-FDG PET/CT 更优识别肝孤立性纤维性肿瘤转移灶
本文报道一例罕见肝孤立性纤维性肿瘤(SFT)伴骨转移病例的增强CT、18F-FDG PET/CT 与 68Ga-FAPI-46 PET/CT 表现。68Ga-FAPI-46 PET/CT 对肝脏肿瘤的靶本比明显更高,并较 18F-FDG PET/CT 显示更多骨转移灶,提示其识别恶性 SFT 转移灶优于 18F-FDG PET/CT。
要点
- 肝 SFT 伴骨转移罕见,本病例对比了增强 CT、18F-FDG 与 68Ga-FAPI-46 PET/CT 表现。
- 68Ga-FAPI-46 PET/CT 对肝脏肿瘤的靶本比明显高于 18F-FDG PET/CT。
- 68Ga-FAPI-46 PET/CT 较 18F-FDG PET/CT 显示更多骨转移灶。
核心结论
- 本病例显示 68Ga-FAPI-46 PET/CT 在识别恶性 SFT 转移灶方面优于 18F-FDG PET/CT。
- 该观察可能为 FAPI PET/CT 在 SFT 分期中的获益增添信息。
研究设计与样本
- 本文为病例报告,报告一例罕见肝 SFT 伴骨转移的增强 CT、18F-FDG PET/CT 与 68Ga-FAPI-46 PET/CT 表现。
主要发现
- 68Ga-FAPI-46 PET/CT 显示肝脏肿瘤的靶本比明显高于 18F-FDG PET/CT。
- 68Ga-FAPI-46 PET/CT 较 18F-FDG PET/CT 显示更多骨转移灶。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Solitary fibrous tumors (SFTs) are fibroblast tumors that occur mainly in the pleura. Hepatic SFT with skeleton metastases was rarely documented. In this case, we report the contrast-enhanced CT, 18 F-FDG, and 68 Ga-FAPI-46 PET/CT findings of a rare hepatic SFT with bone metastases. 68 Ga-FAPI-46 PET/CT showed much higher tumor-to-background contrast of hepatic tumors and revealed more metastatic bone lesions than 18 F-FDG PET/CT. This case demonstrated the superiority of 68 Ga-FAPI-46 PET/CT over 18 F-FDG for identifying metastatic lesions in malignant SFTs. This observation may add information on the benefit of FAPI PET/CT in SFT staging.
引用
- Fu K, Zhao L, Cai J, et al. Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 PET/CT Than 18 F-FDG PET/CT in Hepatic Solitary Fibrous Tumor. Clin Nucl Med. 2024. PMID: 39354687. doi:10.1097/RLU.0000000000005453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。